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Background: This study sought to investigate whether correction of exercise-induced desatura-
tion by oxygen supply (O2) systematically improves exercise tolerance and cardiorespiratory
adaptations in COPD patients.
Methodology: Twenty-five COPD patients [FEV1Z 52  2.5% pred] exhibiting exercise-induced
desaturation performed cyclo-ergometer endurance exercise at 60%of their maximal workload
in two randomized conditions: air vs. O2. O2 was adjusted to ensure 90  SpO2  95%. Endur-
ance time (Tlim), dyspnoea, ventilation ( _VE), breathing frequency (fb), tidal volume (VT),
cardiac output (CO), heart rate (HR) and arterio-venous difference in oxygen (AVD) were
compared between conditions.
Results: The comparison of whole group performance between conditions revealed no differ-
ences, but individual analysis showed that O2 increased Tlim for 14 patients [þ68%; p < 0.01;
(positive responders)], decreased it for seven [36%; p < 0.05; (negative responders)] and in-
duced no change for four (non-responders). For positive responders, improved performance
was supported by reduced dyspnoea, _VE, fb, HR and CO and increased AVD. For negative re-
sponders, hyperoxia resulted in increased dyspnoea and fb without change in _VE or cardiovas-
cular parameters.
Conclusion: For comparable correction of exercise desaturation, O2 does not induce similar
effects on exercise responses in all patients. These results were confirmed in complementary67 415 735; fax: þ33 467 415 750.
alvie.fr (N. He´raud).
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Correction of exercise-induced hypoxemia in COPD 1277study with 11 consecutives patients at higher exercise intensity. For Rþ, we recorded the
classic and expected O2 effects on cardiorespiratory adaptations (i.e. reduced ventilatory de-
mand and cardiac output). In the other group, exercise breathing frequency and dyspnoea
were paradoxically increased despite desaturation correction. However, this study must be
considered as pilot study, which will need to be confirmed in future studies conducted on
a larger case series.
ª 2008 Elsevier Ltd. All rights reserved.Introduction
An increasing number of patients with moderate-to-severe
COPD are entering pulmonary rehabilitation programmes.
During exercise training, some patients with mild resting
hypoxemia present clinically significant desaturation.1,2 To
correct this exercise training-induced desaturation and
insure optimal exercising, these patients might benefit
from acute oxygen supply. However, the literature
indicates that the effects of acute oxygen administration
on exercise tolerance and related symptoms have often
been contradictory. Some investigations have reported
benefits from acute oxygen supply during exertion,3e5
including increased exercise performance, reduced dysp-
noea, and better cardiorespiratory adaptations, whereas
other studies have reported no improvement.6e8 These con-
troversial responses can be explained by the different
methods used in the studies, as considerable inter-study
variability has been noted especially regarding baseline
disease severity,9 mode of oxygen delivery,10e12 and exer-
cise protocol.3,10,13,14
Nevertheless, evidence has also accumulated suggest-
ing that mere methodological considerations are probably
insufficient to explain these different responses to acute
oxygen supplementation. Even in studies in which sub-
jects have undergone the same procedures,6,8,14,15 differ-
ential behaviors were sometimes observed. Notably, in
a recent study of desaturation during an exercise test
in COPD patients, Jolly et al.8 showed marked differences
in individual response during oxygen supplementation.
Unfortunately, because of the wide inter-subject variabil-
ity in exercise SpO2 correction in this study, it is difficult
to know whether their findings were due to differential
responses or to different levels of hypoxemia correction.
Moreover, during 6-min walking tests in COPD patients
with exercise-induced desaturation, our group observed
that supplemental oxygen induced either an improvement
or no change in walking distance. Surprisingly, we also
observed decreased walking distance in some patients;
that is to say, an unexpected negative response (Delam-
ple et al., personal data). Thus, the effects of acute ox-
ygen supplementation for exercise training-induced
desaturation remain questionable.
The first aim of this study was to determine whether
exercise-induced desaturation correction by acute oxygen
supplementation would always induce better exercise tol-
erance as assessed by endurance time and dyspnoea. In the
case of differential responses, the second aim of this study
was to evaluate the cardiorespiratory adaptations during
oxygen supplementation, as a first step in understanding the
mechanisms underlying the different responses.Methods
Characterization of the global study population
This study was carried out on 25 COPD patients. All were ex-
smokers, presented mild hypoxemia and moderate-to-
severe COPD as defined by the ATS/ERS Statement 200416
(Table 1). Patients unable to perform exercise tests, and
those with medical constraints (neuromuscular problems
or acute coronary syndrome), unstable COPD (i.e. exacer-
bation in the last 2 months) or long-term oxygen supply,
were not included.
All included patients had exhibited exercise-induced
desaturation, defined as a fall 4% of the resting SpO2 value
and an SpO2 <90% during the last 3 min of an incremental
exercise test.
Study approval was granted by the local research ethics
committee and informed written consent was obtained
from all participants.
Pulmonary function test
All subjects underwent a plethysmography (V6200 Autobox,
Sensormedics Corp., Yorba Linda, CA, USA). Measurements
included FVC and forced expiratory volume in 1 second
(FEV1). The FEV1/FVC ratio was calculated. The values
obtained were compared with the theoretical values of
Quanjer et al.17
Blood gas analysis
Arterial blood gaseswere collected fromradial artery samples
at rest as the subjects breathed air and were analysed with
a Phox PlusL (Nova Biomedical, Waltham, MA, USA).
Incremental exercise test
A maximal incremental cycle exercise test was performed
to determine the peak power (Wpeak), peak of oxygen con-
sumption ( _VO2peak) of each subject (Ergometrics 900,
Ergoline D-72475, Bitz, Germany) and to identify exercise-
induced desaturation (inclusion criteria). The maximal
incremental protocol consisted of 3 min of rest, followed
by 3 min of unloaded pedaling and then minute-by-minute
increases in the work rate until exhaustion. The incremen-
tal phase was individualized from a protocol usually used in
clinical practice.1
Gas exchanges were measured continuously using
a breath-by-breath automated exercise metabolic system
(Vmax series 29C, Sensormedics, CA, USA). In order to
identify exercise-induced desaturation, pulse oximetric
saturation (SpO2) was measured continuously during test
using a pulse oximeter (Nonin Onyx, Nonin Medical, Inc.
Minneapolis, MN, USA).
Table 1 Patient characteristics and comparison of selected measurements in positive (Rþ) and negative responders (R)
Variables All patients (nZ 25) Rþ patients (nZ 14) R patients (nZ 7) p value
Anthropometric data
Age (years) 62 (2) 60 (2.6) 64 (5) pZ 0.45 NS
Height (cm) 167 (1) 167 (2) 169 (1) pZ 0.47 NS
Weight (kg) 74.6 (3.6) 77.4 (6) 75 (4.1) pZ 0.77 NS
Resting lung function
FEV1/FVC (% pred) 52 (2.1) 55 (3.3) 49.4 (3) pZ 0.29 NS
FEV1 (% pred) 52 (2.5) 54 (4) 48 (4) pZ 0.26 NS
FRC (% pred) 123 (7) 111 (8) 133 (17) pZ 0.21 NS
RV (% pred) 143 (12) 127 (14) 166 (25) pZ 0.21 NS
TLC (% pred) 105 (4) 99 (4) 110 (9) pZ 0.21 NS
Resting blood gases
PaO2 (mmHg) 67 (2) 65 (3) 71 (2) pZ 0.15 NS
PaCO2 (mmHg) 36 (2) 38 (3) 36 (1) pZ 0.75 NS
SaO2 (%) 93 (1) 93 (1) 94 (0.3) pZ 0.39 NS
Functional exercise capacity
_VO2 (L min
1) 1.08 (0.06) 1.14 (0.07) 1.10 (0.14) pZ 0.79 NS
Abbreviations: RþZ positive responders; RZ negative responders; % predZ percentage of predicted value; FEV1Z forced expira-
tory volume in 1 second; FRCZ functional residual capacity; RVZ residual volume; TLCZ total lung capacity; PaO2Z oxygen arterial
pressure; PaCO2Z carbon dioxide arterial pressure; SaO2Z arterial saturation in oxygen; _VO2 Z peak oxygen uptake during incremen-
tal exercise; NSZ no significant between Rþ and R patients.
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Endurance exercise tests and gas administration
Subjects underwent four endurance exercise tests, two in
air condition and two in hyperoxia, allocated randomly. All
endurance exercises were performed on the same cyclo-
ergometer at a constant work rate equal to 60% of Wpeak
(the intensity used in the exercise training programme18
and recommended in the ATS/ERS statement19). The pedal-
ing rate was kept constant between 50 and 70 rpm. The test
was terminated when the patient could not sustain the
pedaling frequency despite strong and repetitive verbal en-
couragements. For each test, the ECG (Cardiosoft Corina;
Marquette Hellige Medical System; Freiburg, Germany),
pulse oximetric saturation (SpO2) (Nonin Onyx, Nonin Med-
ical, Inc. Minneapolis, MN, USA), fatigue and dyspnoea
were monitored and endurance time (Tlim) was measured.
The gas mixture was delivered continually through a two-
way respiratory valve (Hans Rudolph, Kansas City, MO, USA)
and a face mask (Adult 7930 Series, Hans Rudolph). In the air
condition, the system (AltiTrainer200 and module Hyperox1,
Geneva, Switzerland) released FiO2 equal to 20.9%. In the
O2 condition, the FiO2 was continuously measured and ad-
justed to maintain SpO2 between 90% and 95%.
Evaluation of dyspnoea and fatigue
Dyspnoea was defined as ‘‘the sensation of labored or
difficult breathing’’. It was assessed by a visual analogue
scale (VAS) at rest, during (every 2 min) and at the end of
endurance exercise. The VAS was 100 mm long and ranged
from ‘‘not at all breathless’’ to ‘‘asphyxia’’.
Subjective ratings of leg fatigue were estimated by
asking the question: ‘‘how tired do your legs feel?’’; the
patients responded by indicating a point on the Borg scalethat corresponded to their current symptom intensity at
rest and at the end of exercise.20
Objective rating of muscular fatigue was assessed by
measure of the surface electromyography signal (EMG) from
the vastus lateralis muscle during exercise. EMG was mea-
sured by a pair of Ag/AgCl electrodes placed over the belly
of the muscle. Before electrode application, the skin was
shaved, abraded, and then cleaned with alcohol to minimize
skin impedance. The signal was amplified (gain 2500), filtered
(30e500 Hz), sampled at 2000 Hz and recorded via an acquisi-
tion system (MP30 Biopac Systems Inc., Santa Barbara, CA,
USA) on computer. Themedian frequency (MF)was calculated
from 15 epochs at the beginning and end of exercise to deter-
minewhether themuscular fatiguewascomparableat theend
of exercise in the two conditions.21,22 The MF decrease was
used to quantify the amount of muscle fatigue.
Determination of responses during O2 supplementation
To ensure both the certainty and nature of the response in
the hyperoxic condition, the following two complementary
procedures were used:
e We duplicated the endurance test in each condition
(air and hyperoxia) and the acceptance of concor-
dance between Tlim measures was verified with the
intra-class correlation coefficient.
e Further, inclusion in one or the other group was
accepted only if the positive or negative response
was systematically obtained in the O2 condition.
This last pointwas verifiedby the followingprocedure: from
thetwoattempts innormoxiccondition,Tlimair-minwasdefined
as the shortest endurance time and Tlimair-max as the longest
one. To be included in the negative responder group, a COPD
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twice in the hyperoxic condition. Similarly, to be included in
the positive responder group, a COPD patient had to exhibit
a Tlim value 10% higher than Tlimair-max twice in the hyperoxic
condition. The 10% threshold was chosen in accordance with
Jolly’s criteria.8 The patients who exhibited a response under
the 10% threshold were considered as non-responders.Cardiorespiratory adaptations during
endurance exercise
During all exercise gas exchanges were measured continu-
ously using a breath-by-breath automated exercise meta-
bolic system (Vmax series 29C, Sensormedics, CA, USA).
Before exercise, the volume and gases were systematically
calibrated. Oxygen consumption ( _VO2), minute ventilation
( _VE) and the breathing pattern variables [tidal volume (VT),
breathing frequency (fb)] were averaged every 20 seconds.
A 12-lead ECG (Cardiosoft Corina; Marquette Hellige Medical
System; Freiburg, Germany) was continuously monitored.
Cardiac output (CO), stroke volume (SV) and heart rate
(HR)weremeasured at rest and during the endurance tests by
a non-invasive system (Physio Flow, Manatec Biomedical,
Paris, France) which was recently validated in COPD pa-
tients.23The system isbasedonanalysis of instant thoracic im-
pedance variations, using six electrodes (2 for ECG
measurement and 4 for impedance cardiography). Two sets
of electrodes (Ag/AgCl, Dorvit Skintact, FS 50, Innsbruck, Aus-
tria), one transmitting and one sensing, were applied to each
subject at the left base of the neck and along the xiphoid.
The arterio-venous difference in oxygen (AVD) was
calculated from measured CO and _VO2.
Study design
In an initial screening visit, patients underwent plethys-
mography and performed a symptom-limited incremental
cycle exercise test in room air condition. If exercise-
induced desaturation occurred during this test, patients
were included in the study. The study then consisted of four
visits separated by 24 h. Each day, the subjects performed
endurance cycling exercise at a constant work rate equal to
60% of Wpeak. During these submaximal endurance tests,
subjects breathed air or oxygen and were systematically
blinded with respect to the gas mixture. The two conditions
(air vs. oxygen) were randomized and duplicated.
Complementary study
To complete this preliminary experiment and verify the
existence of potential differential responses to oxygen
supply at higher intensity, we have tested 11 consecutives
COPD patients at 80% of Wpeak. As in previous experiment,
these 11 consecutives COPD patients were included
because they have exhibited exercise-induced desaturation
during a symptom-limited incremental cycle exercise test
in room air condition. The complementary study then con-
sisted of two visits separated by 24 h. Each day, patients
performed an endurance cycling exercise at a constant
work rate equal to 80% of Wpeak. During these submaximal
endurance tests, subjects breathed air or oxygen andwere systematically blinded with respect to the gas mix-
ture. The two conditions (air vs. oxygen) were randomized.
Statistical analysis
Data are expressed as mean (SE) values. Between-group
comparisons of anthropometric, basal lung function, and
resting arterial blood gas variables, as well as endurance
performance,weremadewith unpaired t-tests or aWilkoxon
signed rank when the normality test failed.
The concordance of Tlim across the two trials under
each condition (air and O2) was assessed by the intra-class
correlation coefficient.
The cardiorespiratory data assessed during endurance
exercise were expressed at 20, 40, 60, 80 and 100% of
isotime. Isotime was defined as the shortest Tlim achieved
whatever the condition (air or O2 supplementation).
According to the dependent variable analysed, a two or
three-way ANOVA was used. When the ANOVA F ratio was
significant, the means were compared using a post-hoc
LSD procedure.
The relative contributions of HR, SV and AVD (used as
explanatory variables) to explain the variance in _VO2 were
assessed using multiple stepwise regression analysis. This
was performed in each group, with variables measured at
100% isotime.
The results were considered as statistically significant
when p values were 0.05. The data were analysed with
a statistical package (STATISTICA 7.1).
Results
Twenty-five patients met the inclusion criteria and were
included in the principal study. They showed mild hypox-
emia with normal PaCO2 at rest and moderate airflow
obstruction (Table 1).
The comparison of endurance times in the whole group
revealed no statistical difference between air and O2 condi-
tions [1248 (182) vs. 1425 (154) s, respectively; pZ 0.46]
(Table 2). The mean intra-class correlation coefficients of
Tlim were 0.95 in air and 0.68 in O2 condition.
Identification of the different oxygen responses
On the basis of the individual responses during hyperoxic
exercise, we observed a systematic positive response in 14
patients (Rþ), a systematic negative response in seven
patients (R) and no response in four patients (not included
in the following results). For Rþ, themean Tlim increased 68%
and for R, the mean Tlim decreased 36% (Table 2).
The main characteristics of the Rþ and R patients are
presented in Table 1. No statistical differences were noted
between the two subgroups for anthropometric, basal lung
function or resting arterial blood gas variables.
While breathing air, the R patients achieved longer
endurance times than the Rþ patients [1866 (223) vs. 806
(117) s, respectively; p < 0.001] (Table 2) despite similar
desaturation levels (Table 3) and exercise intensity
(expressed in relative or absolute value) (Table 1). Fatigue
levels were also comparable at the end of the endurance
exercises since we observed a similar increase in the Borg
Table 2 Endurance performance of positive (Rþ) and negative responders (R)
Variables All patients (nZ 25) Rþ patients (nZ 14) R patients (nZ 7) p value (Rþ vs. R)
Tlim air (s) 1248 (182) 806 (117) 1866 (223) p < 0.001
Tlim O2 (s) 1425 (154) 1360 (121) 1195 (99) NS; pZ 0.39
p value (air vs. O2) NS; pZ 0.46 p < 0.05 p < 0.05
Abbreviations: TlimZ endurance time obtained in air and O2 condition; NSZ no significant differences.
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frequency of the vastus lateralis in both groups (p > 0.35).
In hyperoxic condition, despite the opposite oxygen
effects on exercise endurance (Tlim increase for Rþ and
decrease for R) a similar increase in the Borg rating of
fatigue in the two subgroups was observed (time effect;
p< 0.001) (Table 4). The electromyographic evaluation also
showed that exercise-induced similar muscle fatigue in Rþ
and R groups (i.e. a comparable drop in the vastus lateralis
median frequency inall conditions;p ranged from0.22 to0.68).
The FiO2 needed to maintain the exercise SpO2 between
90 and 95% was not significantly different between groups
(23  0.5% for Rþ vs. 25  1% for R; p > 0.16).
Cardiorespiratory adaptations during
endurance exercise
Respiratory responses and dyspnoea
The time course of changes in ventilation and breathing
pattern in the air and O2 conditions of Rþ and R patients
are shown in Fig. 1.
In both groups, resting values for all parameters were
comparable in air and O2 conditions.
In Rþ group, oxygen induced significant reduction in _VE
from 40% isotime (p < 0.001) up to isotime and in breathing
frequency (fb) (for all % isotime; p < 0.001) and no change
in VT (p ranged from 0.11 to 0.58).
In contrast, in R group, oxygen induced a significant
increase in fb from 60% isotime up to isotime (p ranged from
0.05 to 0.001) without any significant change in _VE (p
ranged from 0.81 to 0.93) or VT (p ranged from 0.13 to
0.16) compared with air condition.
At end-exercise, no significant difference in any venti-
latory variable was observed in either group.
Concerning dyspnoea (Table 4), oxygen supplementation
induced a significantly decreased score in the Rþ group
(p < 0.01) and a significantly increased one (p < 0.01) in
the R group at isotime.
Oxygen consumption and cardiovascular variables
In both groups, no significant difference in _VO2values was
observed between air and O2 conditions during exerciseTable 3 SpO2 in Rþ and R groups at rest and during exercise
SpO2 All patients (nZ 25) Rþ
Air O2 Ai
Rest 93 (1) 94 (1) 93
Exo 85 (1) 94 (0.5) 85
p values Rest vs. Exo p < 0.001 pZ 0.68 p
Abbreviations: SpO2: partial saturation in oxygen; Rest and ExoZ m
3 min of exercise in air and O2 condition; NSZ no significant differen(p ranged from 0.10 to 0.99). However, in air condition,
the multiple stepwise regression analysis showed that Rþ
patients were primarily dependent on AVD and R were
dependent on SV to reach comparable levels of _VO2at
100% of isotime (Table 5).
In the Rþ group, the comparison of cardiac parameters
during exercise showed an oxygen effect for CO (p < 0.05)
and HR (p < 0.01) (Fig. 2) but no effect for SV (p ranged
from 0.28 to 0.93). Indeed, during oxygen supplementa-
tion, we observed systematically lower HR and CO values
than in air condition. In contrast, in R group, HR, CO
and SV values were comparable between air and O2
conditions.
Likewise, while we observed a systematically higher AVD
in O2 condition in the Rþ group (p < 0.05), similar results (p
ranged from 0.15 to 0.99) were obtained in the two condi-
tions for the R group (Fig. 2).
Results of the complementary study
The main characteristics of 11 new consecutives patients
are presented in Table 6. As in previous group, patients
showed mild hypoxemia with normal PaCO2 at rest and
moderate to severe airflow obstruction.
Identification of the different oxygen responses
On the basis of the individual responses during hyperoxic
exercise, we observed at 80% of Wpeak, a positive response
in eight patients (Rþ) and a negative response in three
patients (R). For Rþ, the mean Tlim increased 45% and
for R, the mean Tlim decreased 23%.
No statistical differences were noted between the two
subgroups for anthropometric, basal lung function or
resting arterial blood gas variables (Table 6).
In air condition, the Rþ and R patients achieved
comparable endurance time [179 (24) vs. 188 (102) s, re-
spectively; pZ 0,49] and exhibited no significant differ-
ence concerning desaturation levels (SpO2Z 85 (1) and 88
(1) % for Rþ and R respectively; pZ 0.19).
Dyspnoea scores and fatigue levels at the end of exercise
were also comparable between Rþ and R (Table 7).patients (nZ 14) R patients (nZ 7)
r O2 Air O2
(1) 93 (1) 94 (1) NS 94 (1) NS
(1) 94 (0.3) 88 (1) NS 94 (0.5) NS
< 0.001 pZ 0.29 p < 0.001 pZ 0.6
ean values recorded during the 3 min of rest and during the last
ce between Rþ vs. R.
Table 4 Ratings of dyspnoea and subjective fatigue in the Rþ and R groups
All patients (nZ 25) Rþ patients (nZ 14) R patients (nZ 7)
Air O2 Air O2 Air O2
VAS (mm) for dyspnoea
Rest 13.5 (4) 12.5 (4.1)
(NS; pZ 0.86)
14.5 (4) 12 (4)
(NS; pZ 0.52)
16 (11) 18 (11)
(NS; pZ 0.58)
Isotime 73 (3.6) 67.6 (4.8)
(NS; pZ 0.37)
79 (4) 63 (7)x 68 (7) 82 (7)x
End 77 (3.5) 77 (4.4)
(NS; pZ 0.96)
79 (4) 79 (6)
(NS; pZ 0.88)
81 (6) 82 (7)
(NS; pZ 0.85)
Borg scale for fatigue
Rest 0.7 (0.17) 0.66 (0.22)
(NS; pZ 0.88)
0.89 (0.26) 0.75 (0.29)
(NS; pZ 0.66)
0.57 (0.29) 0.78 (0.54)
(NS; pZ 0.66)
End 5.17 (0.37) 4.64 (0.43)
(NS; pZ 0.35)
5.4 (0.44)* 5.21 (0.64)*
(NS; pZ 0.58)
5.05 (0.92)* 4.07 (0.76)*
(NS; pZ 0.08)
Abbreviations: VASZ visual analog scale; xZ when values were significantly different (p < 0.01) between air and O2 condition; NSZ no
significant difference between air and O2 condition; *Z when Borg score at rest was significantly different from the score at the end.
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endurance exercise in air condition was comparable with
the maximal HR observed during the symptom-limited
incremental cycle exercise test in room air condition (123
(6.5) vs. 118 (7) respectively for Rþ; pZ 0.12 and 145 (23)
vs. 138 (22) respectively for R; pZ 0.10).
In hyperoxic condition, despite the opposite oxygen
effects on exercise endurance (Tlim increase for Rþ and
decrease for R) a similar increase in the Borg rating of
fatigue in the two subgroups was observed (Table 7). The
HR achieved at the end of endurance time in air and O2 con-
ditions, were also comparable (123 (6.5) vs. 124 (6) respec-
tively for Rþ; pZ 0.95 and 145 (23) vs. 120 (2.5)
respectively for R; pZ 0.48). Concerning dyspnoea, we
observed in both subgroups, similar scores between air
and O2 condition at the end of exercise (Table 7).
Discussion
The aim of this study was to determine whether exercise
tolerance would be systematically improved when exercise-
induced desaturation was corrected by acute O2 supplemen-
tation in COPD patients. The results showed that correction
by acuteO2 supplementation increased theexercise capacity
in two thirds of the patients (Rþ) and significantly decreased
it in about one third (R).Whilewe recorded the standardef-
fects of oxygen in the Rþ group, i.e. reduced ventilatory de-
mand and decreased cardiac output, we observed
a paradoxical increase in breathing frequency in the R
group, associated with increased dyspnoea.
Methodological considerations
From a methodological point of view, this study was
designed: (1) to be as close as possible to exercise training
conditions; and (2) to minimize potential methodological
biases in the identification of differential oxygen responses
(exercise modality, variability in patient commitment and
oxygen administration mode).Therefore, we chose a submaximal constant workload
endurance test because: (1) it is a common type of exercise
proposed in rehabilitation programmes18,19; and (2) it has
greater sensitivity in detecting O2 supply effects than
6-MWT or maximal incremental tests.10,13,15,24 Because
the literature reports considerable variability in endurance
time, we duplicated the test in each exercise condition to
statistically test the concordance of the results. It was
acceptable in both conditions (intra-class correlation coef-
ficientZ 0.95 and 0.68 in air and hyperoxia, respectively).
In addition, to avoid bias, inclusion in the positive or nega-
tive responder group was accepted only if the type of
response in O2 condition was systematically obtained.
Further, the potential interference of subject motivation
in the endurance times (Tlim) was eliminated by the use
of an objective measurement of muscular fatigue (median
frequency drop), which was systematically comparable
whatever the condition and consistent with the findings of
other studies on similar populations.25,26
Regarding the oxygen supplementation mode, we chose
to adapt the FiO2 to maintain exercise SpO2 between 90 and
95% because: (1) SpO2 monitoring is standard for assessing
saturation during exercise training programmes; and (2)
for each patient the supplementation was always adjusted
and individualized. Moreover, this procedure avoided the
occurrence of uncontrolled O2 saturation correction, which
may occur with procedures using the same fixed percentage
of oxygen or gas flow for all patients.6,8,14,15 Besides, in the
case of significant desaturation during exercise, we were
able to deliver needed oxygen quantities without intoler-
ance or discomfort, in contrast to some of the situations
described by Emtner et al.,27 since we increased the FiO2
and not the flow. Moreover, we achieved strictly compara-
ble SpO2 correction by avoiding the major biases due to
breathing pattern (during nasal cannula use). Last, because
we knew the exact quantity of oxygen delivered to each
patient, we are able to state that the differential response
could not have been due to different FiO2 levels since the
subgroups exhibited no significant difference for this
variable.
Figure 1 Changes in breathing pattern during exercise, in air condition (closed triangle) vs. O2 condition (open circles) for Rþ
patients (on the left) and R patients (on the right). _VE Z ventilation; VTZ tidal volume; fbZ breathing frequency.
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A positive response was defined as a systematic improve-
ment in performance (>10%) with oxygen supplementation.
Based on our findings, this performance improvement mayTable 5 Relative part played by cardiorespiratory vari-
ables to explain _VO2variance in the Rþ and R groups
Step # Rþ patients R patients
Variable
selected
Total % of
explained
variance (r2)
Variable
selected
Total % of
explained
variance (r2)
1 AVD 0.29 SV 0.53
2 SV 0.84 AVD 0.86
3 HR 0.91 HR 0.99
All values were recorded at 100% isotime in air condition. Ab-
breviations: _VO2 Z oxygen consumption; AVDZ oxygen arte-
rio-venous difference; SVZ stroke volume, HRZ heart rate.have been due to a combination of factors. Indeed, our
results showed that with oxygen, the ventilation and
breathing frequency were lower for all percentages of
isotime, i.e. the ventilatory demand decreased. Further,
the analysis of cardiac parameters revealed that heart rate
and cardiac output were also reduced. A modulation in the
central nervous command may explain these observations.
The peripheral chemoreceptors are stimulated by oxygen
supplementation.28,29 These stimulations cause an in-
creased afferent influx towards the respiratory and
cardiac centers in the spinal bulb. In response, inhibitor
centers are activated and sympathetic activity is reduced,
leading to a decreased ventilatory drive and heart activity,
especially cardiac output.5,11,30,31 This reduction in ventila-
tory demand, and more especially in breathing frequency,
may induce a decrease in dynamic hyperinflation during ex-
ercise, i.e. an increase in ventilatory capacity and there-
fore decreased breathlessness, as well documented by
Somfay et al.11 and O’Donnell et al.5 The decrease in dysp-
noea scores at isotime is consistent with this hypothesis.
Figure 2 Changes in cardiovascular adaptations during exercise, in air condition (closed triangle) vs. O2 condition (open circles)
for Rþ patients (on the left) and R patients (on the right). COZ cardiac output; HRZ heart rate; AVDZ arterio-venous
difference in oxygen.
Correction of exercise-induced hypoxemia in COPD 1283In accordance with previous studies,32e34 the improved
performance in the Rþ group may also have been depen-
dent on improved peripheral muscular function. Indeed,
as _VO2was the same during exercise in the two conditions,
the decrease in cardiac output during hyperoxia induced
(by application of the Fick principle) an increased oxygen
arterio-venous difference. Because this occurred in associ-
ation with reduced ventilation (and thus reduced oxygen
cost), this indicates that more oxygen was available for en-
ergizing non-respiratory muscles, i.e. effector muscles,
thereby contributing to the improved endurance.11The negative responses
To our knowledge, this is the first time that replicated
negative responses to acute oxygen supply, specifically
regarding exercise endurance, the exercise breathing
pattern or subsequent dyspnoea, have been reported inCOPD patients. Prior to this work, authors have reported
either an increase or no change in performance, but never
a decrease. Three reasons can be advanced to explain the
discrepancy between our results and those of previous
studies. First, most studies analysed their results of acute
O2 supply on the basis of mean responses.
6,11,12 It is thus
highly probable that differential responses were hidden.
This explanation is supported by our results since we
obtained no significant oxygen effect when Rþ and R
were combined into a single group. Second, very few works
specified the criteria to determine the O2 effects.
8,10 And
even in these cases, the authors specified only the positive
response criteria. Therefore, only two groups could be
identified: positive responders (patients who met defined
criteria) and non-responders (all the others). Negative
responders could not be identified. An attentive examina-
tion of the individual data supports this explanation. For
example, in Jolly’s study in 2001, for which individual
values are available, some patients clearly exhibited
Table 6 Patient characteristics and comparison of
selected measurements in positive (Rþ) and negative
responders (R) included in complementary study
Variables All patients
(nZ 11)
Rþ patients
(nZ 8)
R patients
(nZ 3)
Age (years) 64 (4) 66 (2.6) 58 (12) NS
Height (cm) 162 (3) 160 (3) 160 (4) NS
Weight (kg) 63.9 (3.6) 65.3 (5) 60 (4.3) NS
FEV1/FVC
(% pred)
41 (3) 40 (4) 41 (4) NS
FEV1 (% pred) 42 (4) 42.5 (5) 40 (2) NS
FRC (% pred) 147 (21) 135 (28) 180 (13) NS
RV (% pred) 164 (28) 145 (36) 216 (30) NS
TLC (% pred) 108 (11) 102 (16) 123 (8) NS
PaO2 (mmHg) 68 (3) 66 (3) 76 (4) NS
PaCO2 (mmHg) 43 (2) 43 (2) 45 (6) NS
SaO2 (%) 92 (1) 92 (1) 94 (1) NS
_VO2 (L min
1) 0.87 (0.08) 0.83 (0.05) 0.99 (0.32) NS
Tlim air (s) 181 (29) 179 (24) 188 (102) NS
Tlim O2 (s) 227 (32) 251 (26) 170 (98) NS
Abbreviations: RþZ positive responders; RZ negative
responders; % predZ percentage of predicted value;
FEV1Z forced expiratory volume in 1 second; FRCZ functional
residual capacity; RVZ residual volume; TLCZ total lung
capacity; PaO2Z oxygen arterial pressure; PaCO2Z carbon
dioxide arterial pressure; SaO2Z arterial saturation in oxygen;
_VO2 Z peak oxygen uptake during incremental exercise; Tlim
Z endurance time obtained in air and O2 condition during exer-
cise at 80% of the Wpeak; NSZ no significant between Rþ and
R patients (p > 0.01).
1284 N. He´raud et al.decreased performance during exercise under hyperoxia.
The third reason is linked to the methodological consider-
ations cited above (especially the control of SpO2 correc-
tion and the exercise modality).
The comparison of the two groups showed that R did
not differ from Rþ regarding anthropometric and basal
spirometric data, arterial blood gas levels, or functionalTable 7 Dyspnoea scores and subjective fatigue during endura
mentary study
All patients (nZ 11) Rþ
Air O2 Air
VAS (mm) for dyspnoea
Rest 9.9 (4) 8.7 (4.3)
(NS; pZ 0.84)
7.
Isotime 73 (4.8) 67 (6.4)
(NS; pZ 0.44)
7
End 76 (5.3) 73 (4.9)
(NS; pZ 0.65)
7
Borg scale for fatigue
Rest 0.13 (0.07) 0.32 (0.18)
(NS; pZ 0.36)
0.0
End 5 (1.10)* 5.22 (0.97)*
(NS; pZ 0.87)
4.
Abbreviations: VASZ visual analog scale; xZ when values were signifi
significant difference between air and O2 condition; *Z when Borg scand exercise capacity. The FiO2 delivered during the endur-
ance exercise and the exercise intensity (in terms of abso-
lute definition) were comparable. These findings suggest
that negative responses cannot be predicted by resting pul-
monary function, maximal exercise parameters, exercise
desaturation, the O2 quantity delivered or relative
exercise intensity. The only basal parameter that differed
between groups was a higher Tlim in the air condition in
R. This difference cannot be attributed to patient motiva-
tion biases since, in addition to the methodological consid-
erations described above, the relative parts played by
cardiorespiratory variables in the _VO2 levels were clearly
different between the two groups and consistent with
different adjustments to exercise stress. Moreover, it
should be noted that a recent study by Eves et al.35 demon-
strated a comparable result, since the only patient who did
not improve endurance time in O2 condition was the only
one who had a markedly better endurance time in air
condition.
Despite this endurance difference between the two
groups in air condition, the decreased performance with
oxygen supply in this group was surprising because it is
paradoxical.
Our results indicate that the performance decrease
was not determined by cardiac alteration. Indeed, from
a cardiovascular point of view, the R patients exhibited
comparable adaptations in the two conditions. On the
other hand, the analysis of ventilatory adaptations
revealed some potential explanations for this altered
performance. Indeed, we recorded a significant increase
in breathing frequency with oxygen supply in the R
patients for all percentages of isotime. By increasing
their breathing frequency, R probably increased the
ventilatory work and therefore the associated oxygen
cost.36 Since the oxygen arterio-venous difference was
unchanged in this group between the two conditions,
the increase in oxygen delivery to respiratory muscles
was only possible by a redistribution of blood flow from
locomotor muscles.37 This potential decrease innce exercise for the Rþ and R patients included in comple-
patients (nZ 8) R patients (nZ 3)
O2 Air O2
8 (5) 6 (4)
(NS; pZ 0.52)
15 (10) 16 (11)
(NS; pZ 0.58)
4 (6) 63 (8)
(NS; pZ 0.28)
72 (10) 78 (10)
(NS; pZ 0.68)
4 (6) 72 (6)
(NS; pZ 0.88)
84 (12) 78 (10)
(NS; pZ 0.85)
6 (0.06) 0.12 (0.08)
(NS; pZ 0.55)
0.33 (0.16) 0.83 (0.6)
(NS; pZ 0.33)
4 (1.35)* 4.5 (1.21)*
(NS; pZ 0.96)
6.3 (2)* 7.1 (1)*
(NS; pZ 0.40)
cantly different (p < 0.01) between air and O2 condition; NSZ no
ore at rest was significantly different from the score at the end.
Correction of exercise-induced hypoxemia in COPD 1285locomotor muscle blood flow thus appears to be an ex-
planatory factor in the endurance exercise limitation of
R patients. Besides, by increasing their breathing
frequency, it is likely that these patients increased their
dynamic hyperinflation and therefore decreased their
ventilatory capacity and exercise tolerance.5,31 The in-
crease in breathlessness at isotime in this group strongly
supports this hypothesis.Complementary study
To extend the validity of these results, we have decided to
verify the existence of potential difference oxygen
responses for a larger experimental context. From meth-
odological point view, it was thus possible to consider two
aspects: to modify oxygen dose and/or to modify exercise
intensity. Concerning oxygen dose, we have in the main
study, adjusted the FiO2 to maintain the SpO2 between 90
and 95%. The mean SpO2 was thus equal to 94%. Because,
this saturation is clinically relevant and physiologically suf-
ficient to give a good oxygenation to the muscle of all the
patients, it seemed no pertinent to test patients with
higher FIO2.
Consequently, we have chosen to only consider in this
complementary study, a different exercise modality and
more especially higher exercise intensity. In this new
experimental context (endurance exercise at 80% of
Wpeak), we observed again in consecutives patients posi-
tive and negative responses. The proportion of Rþ and
R was also the same that in principal study (2/3 of
Rþ and 1/3 of R). The comparison of two subgroups
showed that Rþ did not differ from R regarding anthro-
pometric and basal spirometric data, arterial gas levels or
functional exercise capacity. Because of this high exer-
cise intensity, the endurance times were brief [181
(29) s in air condition and 227 (32) s in O2 condition]
and the interpretation of cardio-respiratory adaptations
was considered with caution. However, the comparison
of HR at the end of exercise in both subgroups revealed
that patients achieved comparable relative exertion
levels between air and O2 conditions. Likewise, Borg
scores revealed that in both groups, patients have similar
fatigue levels in both conditions.Conclusion
This study shows that in COPD patients the correction of
exercise-induced desaturation by acute O2 supply does not
systematically improve exercise tolerance and the associ-
ated dyspnoea. From a clinical point of view, these results
support the correction of exercise training-induced desatu-
ration in most of patients during rehabilitation programmes.
In contrast, the existence of R reveals that the minimal
quantity of O2 needed to correct exercise-induced desatura-
tion is not always sufficient to improve exercise adaptations.
In addition, the existence of differential responses was con-
firmed with higher intensity exercise. However, this study
must be considered as pilot study offering preliminary in-
sights and tentative conclusions that will need to be con-
firmed in future studies conducted on a larger case series.Acknowledgements
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